You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: limitations and opportunities

Article info

Article menu

Download PDFPDF

Psoriatic arthritis
Viewpoint
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: limitations and opportunities

Authors

  • Michaela Koehm Division of Translational Rheumatology, Immunology, Inflammation Medicine, Goethe University Frankfurt, Frankfurt am Main, Hessen, GermanyClinical Research, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, GermanyClinical Research, Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Frank Behrens Division of Translational Rheumatology, Immunology, Inflammation Medicine, Goethe University Frankfurt, Frankfurt am Main, Hessen, GermanyClinical Research, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, GermanyClinical Research, Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Michaela Koehm; Michaela.Koehm{at}kgu.de
View Full Text

Citation

Koehm M, Behrens F
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: limitations and opportunities
RMD Open 2023;9:e003166. doi: 10.1136/rmdopen-2023-003166

Publication history

  • Received July 2, 2023
  • Accepted September 4, 2023
  • First published September 21, 2023.
Online issue publication 
September 21, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.